LEADER 03867nam 22007335 450 001 9910524871703321 005 20191221113333.0 010 $a0-8135-6389-5 024 7 $a10.36019/9780813563893 035 $a(CKB)4340000000265011 035 $a(OCoLC)986523837 035 $a(MdBmJHUP)muse65330 035 $a(MiAaPQ)EBC5348549 035 $a(DE-B1597)526369 035 $a(DE-B1597)9780813563893 035 $a(EXLCZ)994340000000265011 100 $a20191221d2018 fg 101 0 $aeng 135 $aur|||||||nn|n 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aChildren and Drug Safety $eBalancing Risk and Protection in Twentieth-Century America /$fCynthia A Connolly 210 1$aNew Brunswick, NJ : $cRutgers University Press, $d[2018] 210 4$dİ2018 215 $a1 online resource (p. ) 225 0 $aCritical Issues in Health and Medicine 311 $a0-8135-6388-7 320 $aIncludes bibliographical references and index. 327 $tFrontmatter -- $tContents -- $t1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- $t2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- $t3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- $t4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- $t5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- $t6. Children and Psychopharmacology in Postwar America -- $t7. Pediatric Drug Development and Policy after 1979 -- $tAppendix -- $tAcknowledgments -- $tNotes -- $tIndex -- $tAbout the Author 330 $aChildren and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable. 410 0$aCritical issues in health and medicine. 606 $aHistory, 20th Century 606 $aHealth Policy$xhistory 606 $aDrug and Narcotic Control$xhistory 606 $aDrug Therapy$xstandards 606 $aChild 606 $aDrug Therapy$xhistory 607 $aUnited States 608 $aElectronic books. 610 $achildren medication. 610 $achildren. 610 $adrug safety. 610 $adrug. 610 $adrugs children. 610 $amedication. 610 $apharmaceutical. 610 $apharmacy. 610 $apills. 610 $atherapy. 615 22$aHistory, 20th Century 615 22$aHealth Policy$xhistory 615 22$aDrug and Narcotic Control$xhistory 615 22$aDrug Therapy$xstandards 615 12$aChild 615 12$aDrug Therapy$xhistory 676 $a615.1083 700 $aConnolly$b Cynthia A, $4aut$4http://id.loc.gov/vocabulary/relators/aut.$01045847 801 0$bDE-B1597 801 1$bDE-B1597 906 $aBOOK 912 $a9910524871703321 996 $aChildren and Drug Safety$92566715 997 $aUNINA